ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Stifel lifts J.M. Smucker price target to $132, maintains Hold rating

Analyst raises target on stronger-than-expected Q1 earnings and tariff-related gains, while flagging cautious outlook for coffee volumes and pricing into FY27.

PA
Priya Anand · Equities & Earnings Desk · 27 Aug 2026 · 11:22 · 1 min read
Share
Stifel lifts J.M. Smucker price target to $132, maintains Hold rating

Stifel increased its price target for J.M. Smucker to $132 from $115, maintaining a Hold rating on the shares as the stock approaches its 52-week high.

The upgrade follows the company’s first-quarter results, which exceeded Wall Street expectations. Adjusted earnings per share reached $3.24, surpassing the $2.21 estimate by $1.03. Revenue totaled $2.2 billion, outpacing the $2.12 billion forecast. Stifel attributed $0.84 of the EPS beat to tariff refunds, with an additional $0.20 driven by stronger underlying business performance.

J.M. Smucker’s stock last traded at $130.90, near its 52-week high of $134.85. The shares have gained 38% year-to-date, supported by a 3.4% dividend yield and 16 consecutive years of dividend increases. InvestingPro’s fair-value estimate places the stock at $136.36, suggesting limited upside under current conditions.

The company’s earnings growth benefited from favorable tariff comparisons and refunds, though higher investment spending and inflation partially offset gains. Stifel noted that J.M. Smucker’s FY27 outlook assumes declining coffee volumes and negative pricing for the remainder of the year. The analyst also highlighted progress in debt reduction and an improved outlook for the Uncrustables product line.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT